First Trust Capital Management L.P. Verona Pharma PLC Transaction History
First Trust Capital Management L.P.
- $605 Million
- Q3 2025
A detailed history of First Trust Capital Management L.P. transactions in Verona Pharma PLC stock. As of the latest transaction made, First Trust Capital Management L.P. holds 909,123 shares of VRNA stock, worth $97.2 Million. This represents 16.04% of its overall portfolio holdings.
Number of Shares
909,123Holding current value
$97.2 Million% of portfolio
16.04%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
276Shares Held
77.2MCall Options Held
705KPut Options Held
449K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.27MShares$350 Million10.89% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...